Intex-PCT Pharmaceutical — Research Summary
Intex-PCT Pharmaceutical is a clomiphene citrate formulation developed for post-cycle therapy research applications. Clomiphene citrate is a non-steroidal selective estrogen receptor modulator (SERM) that functions as a competitive antagonist at estrogen receptors in specific tissues whilst demonstrating agonistic properties in others. This pharmaceutical-grade compound represents a valuable research tool for investigators studying estrogen receptor signalling pathways and endocrine system modulation in controlled laboratory environments. Research teams at Stroid UK Shop can evaluate this compound’s tissue-selective properties and its effects on hypothalamic-pituitary-gonadal axis regulation.
Laboratory Research Applications
Researchers investigating endocrine system recovery mechanisms frequently study clomiphene citrate for its ability to modulate estrogen receptor activity. The compound’s dual nature as both an estrogen receptor antagonist and agonist makes it particularly valuable for examining tissue-specific estrogen signalling responses. Laboratory studies examining this formulation alongside other clomiphene citrate research compounds provide insights into selective estrogen receptor modulation. Comparative studies with SARMs research compounds and peptide research products enable comprehensive investigation of different receptor modulation mechanisms and their downstream signalling effects in cellular models.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Clomiphene Citrate |
| Product Code | EU20368 |
| Purity Level | Verify with supplier |
| CAS Number | 50-41-9 |
| Molecular Formula | C₃₂H₃₆ClNO₈ |
| Molecular Weight | 598.08 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Category | Post-Cycle Therapy Compound |
Research Compliance Statement
Intex-PCT Pharmaceutical is manufactured exclusively for in-vitro research purposes and laboratory investigations. This product is not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, adequate ventilation, and appropriate safety measures when handling this compound. All studies should be conducted by qualified personnel in licensed research facilities with proper documentation and adherence to institutional research guidelines and local regulatory requirements.
